Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.14), Zacks reports. The company had revenue of $10.09 million during the quarter, compared to the consensus estimate of $50.00 million. During the […]
Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.14), Zacks reports. The business had revenue of $10.09 million for the quarter, compared to the consensus estimate of $50.00 million. During the […]
Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) shot up 4.1% during trading on Thursday . The company traded as high as $4.15 and last traded at $4.09. 420,001 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 1,664,426 shares. The stock had previously closed at […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report)’s share price was up 4.1% during mid-day trading on Thursday . The company traded as high as $4.15 and last traded at $4.09. Approximately 420,001 shares traded hands during mid-day trading, a decline of 75% from the average daily volume of 1,664,426 shares. The stock had previously […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report)’s stock price traded up 4.1% during mid-day trading on Thursday . The company traded as high as $4.15 and last traded at $4.09. 420,001 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 1,664,426 shares. The stock had previously closed […]